Ernesta Palombo‐Kinne

No ORCID on file · 7 papers in corpus
article 2011
Effect of extended-cycle regimen with an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on bleeding patterns, safety, acceptance and contraceptive efficacy
·doi:10.1016/j.contraception.2011.01.002

BackgroundThe present study compared the efficacy and safety of a combined oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest (EE/DNG) in conventional and extended-cycle regimen over 1 year of treatment.Study designIn …

article 2010
Effects of Combined Oral Contraceptive Ethinylestradiol (30 μg) and Dienogest (2 mg) on Carbohydrate Metabolism During 1 Year of Conventional or Extended-Cycle Use
·doi:10.1055/s-0030-1248263

The effects of extended regimens of combined oral contraceptives (COCs) on carbohydrate metabolism are largely unknown. The present study compared the effects of a COC containing 30 microg ethinylestradiol and 2 mg dienogest (EE/DNG) in con…

article 2009
Effects of an oral contraceptive containing 30 mcg ethinyl estradiol and 2 mg dienogest on lipid metabolism during 1 year of conventional or extended-cycle use
·doi:10.1016/j.contraception.2009.07.011

BackgroundThe effects of extended regimens of combined oral contraceptives (COC) on lipid parameters are largely unknown. The present study compared the effects of a COC containing 30 mcg ethinyl estradiol and 2 mg dienogest (EE/DNG) in con…

article 2008
Efficacy of a combined oral contraceptive containing 0.030 mg ethinylestradiol/2 mg dienogest for the treatment of papulopustular acne in comparison with placebo and 0.035 mg ethinylestradiol/2 mg cyproterone acetate
·doi:10.1016/j.contraception.2008.10.010

BackgroundAcne is a multifactorial disease characterized by androgenic stimulation of sebaceous glands. Therefore, combined oral contraceptives (COCs) containing anti-androgenic progestogens are suitable candidates for acne treatment. This …

article 2008
Efficacy of an oral contraceptive containing 0.030mg ethinylestradiol and 2mg dienogest (EE/DNG) for the treatment of acne – Comparison with placebo and with 0.035mg ethinylestradiol / 2mg cyproterone acetate (EE/CPA)
·doi:10.1055/s-0028-1089030

Introduction: Papulopustular acne is a common skin disease characterized, beside other factors, by androgenic stimulation of sebaceous glands. Combined oral contraceptives (COC) containing progestins with anti-androgenic properties (includi…

article 2006
Zykluskontrolle unter Einnahme von 30µg Ethinylestradiol und 2mg Dienogest im Langzyklus über ein Jahr
·doi:10.1055/s-2006-952281

In einer prospektiven, randomisierten, multizentrischen Studie wurden insgesamt 1315 Frauen im Alter zwischen 18 und 40 Jahren mit 30µg Ethinylestradiol + 2mg Dienogest entweder für 13 konventionelle (21 Tabletten) oder 4 Langzyklen (84 Tab…

article 2004
Influence of a continuous combined HRT (2 mg estradiol valerate and 2 mg dienogest) on postmenopausal depression
·doi:10.1080/13697130400001802

OBJECTIVE: This randomized, double-blind, placebo-controlled study was planned to investigate the effects of continuous combined hormone replacement therapy (HRT) with 2 mg estradiol valerate and 2 mg dienogest (Climodien/Lafamme) over 24 w…